Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology, and COVID-19 Clinical Research Studies.
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2.
Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudine.
The Coronavirus helicase in replication.
Positive‐strand RNA viruses—a Keystone Symposia report
The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
Stabilized coronavirus spike stem elicits a broadly protective antibody
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Reovirus RNA recombination is sequence directed and generates internally deleted defective genome segments during passage.
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Reovirus RNA recombination is sequence directed and generates internally deleted defective genome segments during passage
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase